SUPN Earnings & Financial Statements - Supernus Pharmaceuticals, Inc. logo

SUPN Earnings & Financial Statements

Supernus Pharmaceuticals, Inc.

$28.96
-$0.08(-0.28%)
36
Overall
45
Value
27
Tech
36
Quality
How is this score calculated?
Market Cap
$6.03B
Volume
2.71M
52W Range
$25.92 - $59.68
Target Price
$49.89

SUPN earnings and financial statements: Supernus Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.

SUPN Annual Financial Statements

SUPN income statement
Fiscal year20262025202520252024
Revenue$317.00M$718.95M$314.00M$266.00M$1.19B
Cost of revenue$40.00M$74.56M$83.00M$44.00M$231.00M
Operating income$137.00M-$36.86M$43.00M$67.00M$42.00M
EBITDA$144.00M$304.00M$50.00M$76.00M$97.00M
Net income$89.00M-$38.55M$43.00M$48.00M$15.00M
EPS (diluted)$0.69$1.64$0.33$0.38$0.05
SUPN balance sheet
Fiscal year20262025202520252024
Total assets$1.20B$1.45B$1.42B$1.38B$1.31B
Total liabilities$1.34B$390.93M$1.62B$1.66B$1.65B
Shareholders’ equity-$144.00M$1.06B-$207.00M-$286.00M-$327.00M
Cash and equivalents$175.00M$128.45M$445.00M$372.00M$319.00M
Long-term debt$500.00M$30.36M$328.00M$341.00M$347.00M
SUPN cash flow statement
Fiscal year20262025202520252024
Operating cash flow-$10.00M$47.33M$195.00M$73.00M$36.00M
Capital expenditure--$1.34M---$725.0K
Free cash flow-$30.00M$45.99M$153.00M$68.00M$7.00M
ABCD
1SymbolPriceChangeVol
2SUPN$28.96-0.3%2.71M
3
4
5
6

Get Supernus Pharmaceuticals, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.